4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001632
10% owner bought 47,410 shares at an average $4.82 ($228,529)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-01-21 | Purchase | +24,703 | $4.94 | $122,033 | 5,040,579 | D: show line 1 in the form |
| Cambrian BioPharma Inc 10% owner | 2022-01-24 | Purchase | +22,707 | $4.69 | $106,496 | 5,063,286 | D: show line 2 in the form |
| Open-market purchases · 47,410 sh · avg $4.82 · $228,529 | |||||||
Loading xslF345X03/doc1.xml…